This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Gmbh. Active years: 1981.
Company Filing History:
Years Active: 1981
Title: The Innovations of Kuhn Max
Introduction
Kuhn Max is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his work on cyclosporin derivatives. His innovative approach has led to advancements in treatments for various medical conditions.
Latest Patents
Kuhn Max holds a patent for "Cyclosporin derivatives, their production and pharmaceutical." This patent includes compounds of formula I selected from the group consisting of cyclosporin G, dihydrocyclosporin G, and isocyclosporin G. These compounds are recognized for their usefulness in treating inflammations and arthritis, as well as serving as immuno-suppressant agents. He has 1 patent to his name.
Career Highlights
Kuhn Max is associated with Sandoz GmbH, a prominent company in the pharmaceutical industry. His work at Sandoz has allowed him to focus on developing innovative solutions that address critical health issues. His research has had a lasting impact on the field of immunology and pharmacology.
Collaborations
Throughout his career, Kuhn Max has collaborated with esteemed colleagues such as Hans Hofmann and Rene P Traber. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Kuhn Max's contributions to the field of pharmaceuticals, particularly through his patent on cyclosporin derivatives, highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the treatment of various medical conditions, showcasing the importance of innovation in the pharmaceutical industry.